CaV1.3 antagonist-1
CaV1.3 antagonist-1 is a potent and highly selective CaV1.3 L-type calcium channel (LTCC) antagonist with an IC50 of 1.7 μM. CaV1.3 antagonist-1 inhibits CaV1.3 LTCC >600-fold more potently than CaV1.2 LTCC. CaV1.3 antagonist-1, a cyclopentyl derivative, has the potential for Parkinson's disease research[1].
Product Specifications
CAS Number
1391385-57-1
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cav1-3-antagonist-1.html
Purity
98.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(C2CCCC2)C(CC(N1CCC3=CC=CC(Cl)=C3)=O)=O
Molecular Formula
C17H19ClN2O3
Molecular Weight
334.80
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
L-type calcium channel
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD100 (Semaphorin-4D) (A8), CF568 conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
Pmel17 / gp100 / SILV (NKI-beteb), CF640R conjugate, 0.1mg/mL
Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF640R conjugate, 0.1mg/mL
